- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/02 - Nasal agents, e.g. decongestants
Patent holdings for IPC class A61P 11/02
Total number of patents in this class: 773
10-year publication summary
|
27
|
26
|
37
|
44
|
48
|
55
|
54
|
46
|
47
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Taisho Pharmaceutical Co., Ltd. | 860 |
18 |
| Daiichi Sankyo Company, Limited | 1877 |
13 |
| Schering Corporation | 413 |
11 |
| The Procter & Gamble Company | 21989 |
10 |
| KYORIN Pharmaceutical Co., Ltd. | 169 |
10 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 296 |
9 |
| Santen Pharmaceutical Co., Ltd. | 599 |
9 |
| Shionogi & Co., Ltd. | 835 |
9 |
| Cyrano Therapeutics, Inc. | 39 |
9 |
| Dainippon Sumitomo Pharma Co., Ltd. | 178 |
8 |
| Kyowa Hakko Kirin Co., Ltd. | 280 |
8 |
| Mitsubishi Tanabe Pharma Corporation | 558 |
8 |
| Igisu Co., Ltd | 22 |
7 |
| Mochida Pharmaceutical Co., Ltd. | 336 |
7 |
| Ono Pharmaceutical Co., Ltd. | 428 |
7 |
| Takeda Pharmaceutical Company Limited | 2717 |
6 |
| Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH | 149 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4444 |
6 |
| Merck Sharp & Dohme Corp. | 2190 |
5 |
| Astellas Pharma Inc. | 1057 |
5 |
| Other owners | 602 |